Provider records sourced from NPPES (CMS National Plan & Provider Enumeration System). Data current as of August 10, 2026.

Jonathan M. Gerber

Individual provider Medical Oncology Physician · NPI 1275679201

Jonathan M. Gerber practises Hematology in New York, New York. Qualified in 1999, 27 years ago. Practices with New York University, a 5,884-clinician group and accepts Medicare assignment. Licensed in New York.

Years since qualifying
27
Licensed in
NY
In the registry since
2007
Specialties on file
2

Practice location Address checks out

610 2nd Ave Fl 2
New York, NY 10016-4859
Phone: (646) 501-4848
Fax: (929) 455-9087
Show map & directions

Pin is approximate — placed at the ZIP-code centre, not the exact door.

Specialties & licences

Hematology (Internal Medicine) Physician (primary) Taxonomy 207RH0000X · Licence 329301 (NY)
Medical Oncology Physician Taxonomy 207RX0202X · Licence 329301 (NY)

Record details

NPI number1275679201
Entity typeIndividual (Type 1)
GenderMale
Sole proprietorNo
NPI enumeratedJanuary 29, 2007
Last updated in NPPESMarch 26, 2025
Certification dateMarch 26, 2025

Medicare enrollment

From the CMS Doctors & Clinicians file — this clinician is enrolled in Medicare.

Medicare specialtyHEMATOLOGY
Also practisesMEDICAL ONCOLOGY
Medical schoolOTHER
Graduated 1999 (27 years in practice)
Group practice New York University — 5884 clinicians
Accepts Medicare assignment Yes — accepts the Medicare-approved amount
Practice locations4 on file with Medicare

Medicare patients and services, 2024

From the CMS Medicare Physician & Other Practitioners file for calendar year 2024. It counts Original Medicare patients only, so a practice that mostly sees Medicare Advantage or privately insured patients looks smaller here than it is.

Medicare patients29
Services billed 106 a service is one billed item, such as a visit, a test or a procedure
Average patient age72

Dollar amounts are not shown. What Medicare pays a practice is gross billings, before staff, premises and tax and including the cost of any drugs it administers, so it is not what a clinician earns.

Payments from drug and device companies, 2025

Drug and device makers are required by federal law (the Physician Payments Sunshine Act) to report what they pay or give to clinicians, and CMS publishes the reports as Open Payments. This is the 2025 program year. A report is a record of a payment, not an allegation of anything, and many are small items such as meals. Only general payments are listed here; research payments and ownership or investment interests are reported separately by CMS and are not shown.

Food and Beverage $244 2 payments · a meal or drink at a meeting or visit, not a fee

Each amount is the sum of what companies reported for that kind of payment in 2025, rounded to the dollar. Not all of it is income to the clinician: a meal is not a fee, a charitable contribution goes to a charity, and a royalty or an acquisition payment is not a salary.

Check a report, or dispute one, at the source in CMS’s own tool, Open Payments. Corrections go through CMS’s dispute process. This site removes a home address on request and asks for no proof, because that is privacy; it will not remove an accurate payment report on request, because that is a statutory public disclosure.

Practises at

Facilities the CMS Facility Affiliation file lists for this clinician.

Colleagues at New York University

Clinicians the CMS Doctors & Clinicians file lists under the same group practice. CMS counts 5884 clinicians in the practice; 12 are shown here.

Other providers in New York